AventaMed Ltd.
Office-based, one-shot tympanostomy tube placement
This article was originally published in Start Up
Executive Summary
More than 2.2 million cases of otitis media with effusion are diagnosed each year worldwide, with as many as 90% of children having at least one episode by age 10. The standard treatment is surgical placement of tiny tympanostomy tubes to ventilate the middle ear space, but AventaMed Ltd. is working to dramatically reduce costs in treating OME and to improve the patient experience with a novel device for tympanostomy tube placement that takes less than one second in an office setting.
You may also be interested in...
Sandoz Prepares For European Natalizumab Launch As Approval Arrives
As it announced the formal European Commission approval of its partnered Polpharma Biologics-developed Tyruko natalizumab biosimilar to Tysabri, Sandoz offered Generics Bulletin a timeframe for its expected launch in Europe.
Biopharma’s Must-Know Q4 Catalysts
Cytokinetics has a lot riding on the upcoming Phase III readout for aficamten, and crunch time is coming for plenty of other groups, too.
Stock Watch: Exploring Biotech’s Route Through Bubble And Wilderness
Biotech has always been a volatile sector, and it is important for investors to recognize the phases its stocks go through. In particular, the journey through the post-bubble wilderness can be a protracted affair.